Skip to Main Content

Author Details

Pierre P Massion
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
1993
223
58
PMIDPaper TitleJournal TitlePublished Year
36368616Development and Validation of a Risk Assessment Model for Pulmonary Nodules Using Plasma Proteins and Clinical Factors.Chest2023
36368616Development and Validation of a Risk Assessment Model for Pulmonary Nodules Using Plasma Proteins and Clinical Factors.Chest2023
37760474Validation of a Proteomic Signature of Lung Cancer Risk from Bronchial Specimens of Risk-Stratified Individuals.Cancers (Basel)2023
37848457Cancer-associated fibroblasts in early-stage lung adenocarcinoma correlate with tumor aggressiveness.Sci Rep2023
37674811Tumoral Densities of T-Cells and Mast Cells Are Associated With Recurrence in Early-Stage Lung Adenocarcinoma.JTO Clin Res Rep2023
37612638TP53 mutation prevalence in normal airway epithelium as a biomarker for lung cancer risk.BMC Cancer2023
37016707Biomarkers in Lung Cancer Screening: a Narrative Review.Curr Chall Thorac Surg2023
36630482Posttranslational modifications induce autoantibodies with risk prediction capability in patients with small cell lung cancer.Sci Transl Med2023
37760474Validation of a Proteomic Signature of Lung Cancer Risk from Bronchial Specimens of Risk-Stratified Individuals.Cancers (Basel)2023
37848457Cancer-associated fibroblasts in early-stage lung adenocarcinoma correlate with tumor aggressiveness.Sci Rep2023
37612638TP53 mutation prevalence in normal airway epithelium as a biomarker for lung cancer risk.BMC Cancer2023
37674811Tumoral Densities of T-Cells and Mast Cells Are Associated With Recurrence in Early-Stage Lung Adenocarcinoma.JTO Clin Res Rep2023
37016707Biomarkers in Lung Cancer Screening: a Narrative Review.Curr Chall Thorac Surg2023
36630482Posttranslational modifications induce autoantibodies with risk prediction capability in patients with small cell lung cancer.Sci Transl Med2023
3529448618F-FSPG PET imaging for the evaluation of indeterminate pulmonary nodules.PLoS One2022
35763345Ligand-independent integrin β1 signaling supports lung adenocarcinoma development.JCI Insight2022
35748739Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer.Cancer Res2022
35491773The impact of the lung EDRN-CVC on Phase 1, 2, & 3 biomarker validation studies.Cancer Biomark2022
35941262cfDNA methylome profiling for detection and subtyping of small cell lung cancers.Nat Cancer2022
35870539Improving malignancy risk prediction of indeterminate pulmonary nodules with imaging features and biomarkers.Clin Chim Acta2022
35413280The Association of Health Care System Resources With Lung Cancer Screening Implementation: A Cohort Study.Chest2022
35608444Artificial Intelligence Tool for Assessment of Indeterminate Pulmonary Nodules Detected with CT.Radiology2022
36120008Assay Performance of a Label-Free, Solution-Phase CYFRA 21-1 Determination.ACS Omega2022
35332150Integrative network analysis of early-stage lung adenocarcinoma identifies aurora kinase inhibition as interceptor of invasion and progression.Nat Commun2022
3529448618F-FSPG PET imaging for the evaluation of indeterminate pulmonary nodules.PLoS One2022
35033300Association of Rurality With Annual Repeat Lung Cancer Screening in the Veterans Health Administration.J Am Coll Radiol2022
35158979Early-Stage Lung Adenocarcinoma MDM2 Genomic Amplification Predicts Clinical Outcome and Response to Targeted Therapy.Cancers (Basel)2022
35608444Artificial Intelligence Tool for Assessment of Indeterminate Pulmonary Nodules Detected with CT.Radiology2022
35763345Ligand-independent integrin β1 signaling supports lung adenocarcinoma development.JCI Insight2022
35491773The impact of the lung EDRN-CVC on Phase 1, 2, & 3 biomarker validation studies.Cancer Biomark2022
35748739Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer.Cancer Res2022
35413280The Association of Health Care System Resources With Lung Cancer Screening Implementation: A Cohort Study.Chest2022
35941262cfDNA methylome profiling for detection and subtyping of small cell lung cancers.Nat Cancer2022
35870539Improving malignancy risk prediction of indeterminate pulmonary nodules with imaging features and biomarkers.Clin Chim Acta2022
36120008Assay Performance of a Label-Free, Solution-Phase CYFRA 21-1 Determination.ACS Omega2022
35158979Early-Stage Lung Adenocarcinoma MDM2 Genomic Amplification Predicts Clinical Outcome and Response to Targeted Therapy.Cancers (Basel)2022
35033300Association of Rurality With Annual Repeat Lung Cancer Screening in the Veterans Health Administration.J Am Coll Radiol2022
35332150Integrative network analysis of early-stage lung adenocarcinoma identifies aurora kinase inhibition as interceptor of invasion and progression.Nat Commun2022
32682756Validation of Histoplasmosis Enzyme Immunoassay to Evaluate Suspicious Lung Nodules.Ann Thorac Surg2021
35813245Integrated Cells and Collagen Fibers Spatial Image Analysis.Front Bioinform2021
33640962Incorporating both genetic and tobacco smoking data to identify high-risk smokers for lung cancer screening.Carcinogenesis2021
33618009A model based on the quantification of complement C4c, CYFRA 21-1 and CRP exhibits high specificity for the early diagnosis of lung cancer.Transl Res2021
33827979Small airway determinants of airflow limitation in chronic obstructive pulmonary disease.Thorax2021
34257356HLA-DR cancer cells expression correlates with T cell infiltration and is enriched in lung adenocarcinoma with indolent behavior.Sci Rep2021
34354325Measure Partial Liver Volumetric Variations from Paired Inspiratory-expiratory Chest CT Scans.Proc SPIE Int Soc Opt Eng2021
33973553Risk stratification of indeterminate pulmonary nodules.Curr Opin Pulm Med2021
33303552Validation of the BRODERS classifier (Benign <i>versus</i> aggRessive nODule Evaluation using Radiomic Stratification), a novel HRCT-based radiomic classifier for indeterminate pulmonary nodules.Eur Respir J2021
33141593Reply to Wilson: Risk-Stratifying Pulmonary Nodules.Am J Respir Crit Care Med2021
32682756Validation of Histoplasmosis Enzyme Immunoassay to Evaluate Suspicious Lung Nodules.Ann Thorac Surg2021
33422974Protocol to evaluate an enterprise-wide initiative to increase access to lung cancer screening in the Veterans Health Administration.Clin Imaging2021
  • 1 - 50 of 446

Recommended Authors

The Sixth Affiliated Hospital of Guangzhou Medical University
Career Start Year 2018
Number of shared co-authors 0
Yale University School of Medicine
Career Start Year 2014
Number of shared co-authors 0
the First Affiliated Hospital of Guangzhou Medical University
Career Start Year 2013
Number of shared co-authors 1
Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Universite Laval
Career Start Year 2013
Number of shared co-authors 0
UPMC Hillman Cancer Center
Career Start Year 2012
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2012
Number of shared co-authors 11
Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School
Career Start Year 2012
Number of shared co-authors 2
Peking University Cancer Hospital & Institute
Career Start Year 2012
Number of shared co-authors 0
Siteman Cancer Center, Washington University School of Medicine
Career Start Year 2011
Number of shared co-authors 7
Shanghai Pulmonary Hospital, Tongji University School of Medicine
Career Start Year 2010
Number of shared co-authors 3
Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund
Career Start Year 2008
Number of shared co-authors 0
National Cancer Center Exploratory Oncology Research & Clinical Trial Center
Career Start Year 2008
Number of shared co-authors 1
Western University
Career Start Year 2008
Number of shared co-authors 1
College of Biology and Food, Shangqiu Normal University
Career Start Year 2007
Number of shared co-authors 8
Quantitative Biomedical Research Center
Career Start Year 2007
Number of shared co-authors 7
Daegu Catholic University Medical Center
Career Start Year 2006
Number of shared co-authors 1
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 1
The First People's Hospital of Zhaoqing
Career Start Year 2003
Number of shared co-authors 3
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 13
Peking University Cancer Hospital & Institute
Career Start Year 2002
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 1
Uppsala University
Career Start Year 1997
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1996
Number of shared co-authors 3
Norris Comprehensive Cancer Center, University of Southern California
Career Start Year 1995
Number of shared co-authors 2
Guangzhou Medical University, First Hospital
Career Start Year 1994
Number of shared co-authors 5
The Princess Margaret Cancer Centre/University of Toronto
Career Start Year 1992
Number of shared co-authors 12
Research Institute in Oncology and Hematology
Career Start Year 1991
Number of shared co-authors 8
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 7
Lund University
Career Start Year 1977
Number of shared co-authors 6
University Health Network, University of Toronto
Career Start Year 1972
Number of shared co-authors 26

Collaborators

Veterans Affairs Tennessee Valley Healthcare System
Co-authored papers 31
Vanderbilt University Medical Center
Co-authored papers 29
Vanderbilt University
Co-authored papers 15
Vanderbilt University Medical Center
Co-authored papers 11
Mass Spectrometry Research Center, Vanderbilt University
Co-authored papers 10
12328Vanderbilt University Medical Center
Co-authored papers 9
Tennessee Valley Healthcare System
Co-authored papers 9
University of Texas Southwestern Medical Center at Dallas
Co-authored papers 8
Vanderbilt University Medical Center
Co-authored papers 8
Vanderbilt University Medical Center
Co-authored papers 8
Laura and Isaac Perlmutter Cancer Center
Co-authored papers 7
Vanderbilt-Ingram Cancer Center
Co-authored papers 7
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
Boston University School of Medicine
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
Vanderbilt-Ingram Cancer Center, and Education Clinical Center (GRECC)
Co-authored papers 6
Department of Pediatrics Stanford University Stanford California USA.
Co-authored papers 5
University of North Carolina at Chapel Hill
Co-authored papers 4
Vanderbilt University Medical Center
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Health Services Research & Development
Co-authored papers 3
Vanderbilt University Medical Center
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
University of California Los Angeles
Co-authored papers 3
David Geffen School of Medicine at university of california los angeles
Co-authored papers 3
Vanderbilt University Medical Center
Co-authored papers 3
American College of Medical Informatics, Department of Veteran Affairs, Harvard University T H Chan School of Public Health, Massachusetts Institute of Technology, The American Society for Clinical Investigation, University of Kentucky, Vanderbilt University Medical Center, Vanderbilt University Medical School
Co-authored papers 3